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INTRODUCTION 
Diabetes mellitus is common metabolic disease world-
wide and type 2 diabetes mellitus (T2DM) is the com-
monest form of diabetes. The chronic hyperglycaemia 
in diabetes mellitus is usually associated with long-
term damage and spectrum of complications involving 
various systems mainly eyes, nerves, kidneys, and 
heart. [1] In initial stages, the illness remains silent and 
asymptomatic which delays the diagnosis and thereby 
increases the risk of complications. The actual onset of 
diabetic hyperglycaemia and clinical diagnosis has 
asymptomatic phase lasting for approximately 4-7 
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years, resulting in 30-50% of population remaining un-
diagnosed. [2] Thus, there exists quite some population 
with hyperglycaemia who are untreated in T2DM. This 
unchecked hyperglycaemia which prevails during the 
asymptomatic phase may account for high prevalence 
of microvascular complications even in newly detected 
T2DM. In fact, the significant morbidity and mortality 
in T2DM can be attributed to the microvascular and 
macrovascular complications.[3] Microvascular compli-
cations include retinopathy, nephropathy, and neurop-
athy which has been well established in literature. [3,4] 
Many research studies conducted worldwide, have 
been conclusive of lung being target organ in diabetes 
mellitus [5, 6] thus adding a further to the list of micro-
vascular complications. The extensive pulmonary mi-
crovascular circulation and abundant connective tissue 
in lungs raises the possibility of it being involved in 
microvascular complications. Various microvascular 
changes in diabetes mellitus show close association 
with one another, as diabetic nephropathy and reti-
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nopathy exits in majority of patients, and one might 
entertain another cause for nephropathy only in the 
absence of retinopathy [7]. Thus, intensity of involve-
ment of kidneys and retina seem to correlate with each 
other. Whether similar association between deranged 
pulmonary functions and other microvascular compli-
cations exists needs to be studied further. Though 
there are many studies which confirm the microvascu-
lar affection of lungs and several comparative studies 
of PFTs in diabetic population with microvascular com-
plications, but there are hardly any studies on associa-
tion of lung function tests with individual microvascular 
complications, retinopathy and nephropathy.  The pre-
sent study was carried out to study the pulmonary 
function tests in T2DM and assess its association with 
microvascular complications, particularly nephropathy 
and retinopathy. 
In view of increased prevalence of microvascular com-
plications in the eyes and kidneys, diabetic patients are 
advised regular screening of retina and periodic urine 
examination. Whether similar association between 
deranged pulmonary functions and other microvascu-
lar complications exists needs to be studied further. [8] 
Unlike this, screening for lung functions is not regular 
phenomenon in Indian diabetic population. Whether 
evaluation of lungs by PFT's needs to be incorporated 
for regular screening, as is done for retina and kidney 
in T2DM would depend on chronicity and intensity of 
lung involvement. The intensity of involvement of the 
lungs vis-a-vis retina and kidneys needs to be studied 
and evaluated.  This aspect  has not been looked in 
detail by previous research studies. Hence further as-
sessment of association of these microvascular compli-
cations (nephropathy, retinopathy, PFT parameters) 
with duration of diabetes was analysed in the present 
study.   
MATERIALS & METHODS 
Study design: An observational, analytical, cross sec-
tional study.  
Ethics approval:  The study was approved by the insti-
tutional ethical review committee and participants 
were recruited for study after obtaining written con-
sent.  
Study location: The present study was conducted in a 
tertiary hospital, Mumbai. 
Sample size: Total 200 participants were included in 
the study.  
Study populations: A total of 100 type 2 diabetic pa-
tients attending diabetic clinic in tertiary hospital were 
selected for the study. 100 non-diabetic subjects be-
longing to the same socio-economic status were select-
ed from the general population for comparison. A de-
tailed medical, personal and family history was ob-
tained followed by general examination.  
Inclusion criteria: Males of age 35- 55 years, Non-
smokers, Type 2 diabetics with HbA1C≥7. 
Exclusion criteria: Obese, Hypertensives, Overt cardiac, 
pulmonary or renal disease due to non diabetic causes. 
Methodology:  
The following anthropometric parameters were stud-
ied: age in years, height in cm, with the help of height 
measurement stadiometer, weight in kg.  
BMI: BMI was measured by the formula BMI = Weight 
(in Kg) / Height (in m2).   
Glycosylated haemoglobin: HbA1c levels of all subjects 
in the study were determined by ion exchange resin 
method by diagnostic glycohaemoglobin kits of Asritha 
Diatech as per guidelines provided. [9] HbA1c was used 
as an index of diabetic control over last 3 months. Val-
ues over 7.5% were considered as poor glycemic con-
trol.  
Blood glucose estimation: Fasting and postprandial 
blood glucose was estimated by glucose oxidase meth-
od. [10] The oral glucose tolerance test (OGTT) was 
done for control group to exclude diabetes. Only those 
control subjects with a normal fasting blood glucose of 
<110 mg/dL and 2 hours post oral glucose of <140 mg/
dL were selected for study. Fasting blood glucose of 
⩾126 mg/dL was used to define diabetes.  
Serum urea was estimated by Berthelot’s method [11] 
while creatinine was estimated by alkaline Jaffe’s Pic-
rate method. [12] These biochemical parameters were 
determined by using fully automated clinical chemistry 
analyser. The GFR per 1.73 m2 BSA was calculated with 
serum creatinine, urea nitrogen, and albumin levels 
using an equation developed from the Modification of 
Diet in Renal Disease (MDRD) study as follows: GFR = 
170 × [serum creatinine] −0.999×[age]−0.176× [0.762 if 
female] × [1.180 if non-Hispanic black] ×[blood urea 
nitrogen]−0.170×[serum albumin]−0.318.[13]   
The presence of diabetic glomerulopathy was deter-
mined by estimating 24-hour protein excretion rate by 
semi-automated analyser. An albumin excretion rate 
between 30-300 mg per day was considered as indica-
tive of microalbuminuria. [14,15] The presence of reti-
nopathy was determined by using direct ophthalmos-
copy, carried out by an experienced ophthalmologist in 
all the patients. The disease was graded according to 
the diabetic retinopathy disease severity scale as rec-
ommended by the American Academy of Ophthalmolo-
gy. Non-proliferative retinopathy was diagnosed as 
grade 1,2,3 by the presence of cotton wool spots, micro 
aneurysms and boat shaped hemorrhages respectively 
on direct ophthalmoscopic examination. [16] Prolifera-
tive retinopathy was diagnosed by the presence of neo-
vascularization in the retina (grade 4).  
Spirometry was performed in a quiet room in sitting 
position by trained personnel and adequate spirograms 
as per the American Thoracic Society (ATS) guidelines 
was obtained. [17] The PFT helps to detect abnormali-
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ties in lung function even when there are no signs and 
symptoms. The following PFT parameters were meas-
ured: forced vital capacity (FVC), forced expiratory vol-
ume in one second (FEV1), percentage of forced expira-
tory volume in one second (FEV1%).  These measure-
ments are crucial for interpretation of spirometry re-
sults.  If FVC and FEV1 are within 80% of the reference 
value, results are considered normal. The normal value 
for FEV1/FVC ratio is 70%. Best out of the three read-
ings were selected. Mean ± SD were calculated.   
Statistical analysis: Statistical analysis was carried out 
using SSPS software version 21. One-way analysis of 
variance (ANOVA) was used to compare mean values in 
control group and type 2 diabetic patients. Pearson’s 
correlation coefficient was used to quantify the extent 
of relationship between each of PFT parameters FVC, 
FEV1, FEV1% with microalbuminuria, GFR and retinopa-
thy. To study association of microvascular complica-
tions, nephropathy, retinopathy and pulmonary param-
eters with duration of diabetes, type 2 DM patients 
were divided into 2 groups, 1) those with duration less 
than 10 years of diabetes and 2) those with duration 
more than 10 years. Pearson’s correlation coefficient 
was used to study the extent of relationship between 
each of PFTs parameters, nephropathy and retinopathy 
with duration of diabetes. Group comparisons were 
adjusted for the level of severity of retinopathy with 
Chi square test for trend (Mantel–Haenszel method).  
Mantel-Haenszel method produces a single, summary 
measure of association which provides weighted aver-
age of the risk ratio or odds ratio across the different 
strata of the confounding factor. The correlation of 
retinopathy with nephropathy was analysed by 
Spearman's Rank correlation coefficient, which is used 
to identify and test the strength of relationship be-
tween two sets of data. It is often used as a statistical 
method to aid with either proving or disproving a hy-
pothesis. All statistical tests used for analysis were two-
tailed (SPSS software version 21). A p value of < 0.05 
was considered statistically significant. 
RESULTS 
Table 1 indicates mean ± SD for anthropometric meas-
urements in non-diabetic subjects (control group) and 
T2DM / NIDDM. There was no significant difference in 
the age, height, weight and BMI.   
Table 2 indicates mean ± SD of fasting and post meal 
blood sugar levels and glycosylated haemoglobin 
(HbA1c) levels, GFR, micro albuminuria in the control 
and T2DM. There was significant increase in fasting 
blood sugar (FBS) and post meal blood sugar (PBS) lev-
els, HbA1c levels and significant decrease in GFR in 
T2DM as compared to control group. There was signifi-
cant decrease in FVC, FEV1 and FEV1% in T2DM as com-
pared to control group.   
Parameters Groups N Mean ±SD P value Significance 
Age (years) Control 100 50.65 ± 4.983 0.102 NS 
NIDDM  51.1 ± 4.833   
Height (cms) Controls 100 162.27 ± 6.19 0.117 NS 
NIDDM   161.3 ± 5.339     
Weight (kg) 
  
Control 100 56.63 ± 5.571 0.38 NS 
NIDDM   56.88 ± 6.133     
BMI (kg/m2) 
  
Control 100 21.68 ± 2.484 0.225 NS 
NIDDM   21.378 ± 3.15     
SD-Standard deviation, NIDDM- non- insulin dependent diabetes mellitus, BMI- body mass index 
Parameters Groups Mean ± SD P value Significance 
FBS Control 
NIDDM 
80.74±8.967 
102.56±19.552 
0.000 S 
PBS Control 
NIDDM 
127.353±9.054 
182.96±20.515 
0.000 S 
HbA1c Control 
NIDDM 
5.112±0.308 
6.887±0.963 
0.000 S 
GFR 
(ml/min/1.73m2) 
Control 
NIDDM 
125.46±12.665 
90.521 ± 16.29 
0.000 S 
micro albuminuria Control 
NIDDM 
1.3 ± 0.180 
115.06 ± 62.60 
0.000 S 
FVC Control 
NIDDM 
2.761± 0.285 
2.577±0.341 
0.05 S 
FEV1 Control 
NIDDM 
2.384±0.259 
2.091± 0.283 
0.000 S 
FEV1% Control 
NIDDM 
84.741± 4.5 
81.477±4.314 
0.000 S 
P.005 significance, FBS and PBS- fasting and post meal blood sugar, HbA1C- glycosylated hemoglobin SD- standard deviation 
Table 2. Comparison among study groups for FBS, PBS, HbA1c, micro albuminuria, FVC, FEV1, FEV1% 
Table 1. Comparison among study groups for anthropometric measurements  
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Table 3. Mean ± SD of PFT parameters in different grades of retinopathy  
MEAN ±SD 1 2 3 4         P Significance 
FVC 2.655±0.346 2.544±0.212 2.509±0.336 2.45±0.212 0.327 NS 
FEV1 2.173±0.285 2.065±0.286 2.009±0.258 1.9±0.1414 0.098 NS 
FEV1% 82.368±4.358 81.5±4.70 80.590±3.445 78±1.414 0.284 NS 
As the grade of retinopathy increases, there is a non- significant decrease in PFT values  
Table 4. Correlation of Pulmonary function tests: FVC, FEV1, FEV1% with micro albuminuria and GFR.  
Correlation of Parameters r2correlation coefficient t for correlation P value Significance 
FVC with GFR - 0.003 0.033 0.973 NS 
FVC with micro albuminuria 0.081 0.808 0.420 NS 
FEV1 with GFR -0.054 0.536 0.592 NS 
FEV1 with micro albuminuria -0.070 0.697 0.487 NS 
FEV1% with GFR -0.148 1.483 0.141 NS 
FEV1% with micro albuminuria -0.406 4.399 0.05 S 
Table 5. Indicating anthropometric measurements in type 2 diabetics according to duration of illness  
Parameters Duration of diabe-
tes 
Mean ±SD P value Significance 
Age (years) Less than 10 
More than 10 
50.854 ± 4.544 
51.5 ± 5.310 
0.535 NS 
Height (cms) Less than 10 
More than 10 
161.338 ± 5.368 
161.236 ± 5.364 
0.926 
  
NS 
Weight (kg) Less than 10 
More than 10 
57.709 ± 6.361 
55.526 ± 5.559 
0.074 
  
NS 
BMI(kg/m2) Less than 10 
More than 10 
21.966 ± 3.155 
20.420 ± 2.955 
0.015 
  
NS 
SD- standard deviation, NIDDM- non insulin dependent diabetes mellitus, BMI- body mass index 
Table 6. Comparison among type 2 diabetics for FBS, PBS, HbA1c and micro albuminuria according to duration of 
diabetes 
Parameters Duration of diabetes in years Mean ± SD P value Significance 
FBS Less than 10 
More than 10 
95.806 ±17.089 
113.578±18.445 
0.01 
  
S 
PBS Less than 10 
More than 10 
175.596±14.218 
194.973±23.530 
0.01 
  
S 
HbA1c Less than 10 
More than 10 
6.459±0.674 
7.584±0.962 
0.000 
  
S 
GFR 
(ml/min/1.73m2) 
Less than 10 
More than 10 
90.532±4.412 
88.947±2.931 
0.01 S 
micro albuminuria Less than 10 
More than 10 
72.919±51.666 
137.289 ±4 0.121 
0.000 S 
FVC Less than 10 
More than 10 
2.619± 0.337 
2.507±0.341 
0.115 NS 
FEV1 Less than 10 
More than 10 
2.132±0.278 
2.023± 0.284 
0.065 NS 
FEV1% Less than 10 
More than 10 
81.903± 4.629 
81± 3.734 
0.287 NS 
Table 7. Association between retinopathy grades and duration of diabetes 
Retinopathy Grades Duration >10 yrs Duration <=10yrs Total 
1 2(5.2%) 36(13.68%) 38 
2 18(47.3%) 20(7.6%) 38 
3 16(72.7%) 6(1.32%) 22 
4 2(100%) 0(0%) 2 
Chi square for trend (extended to Mantel-Haenszel) =33.57, p value =0.000, S 
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Table 3 shows mean ± SD of the FVC, FEV1 and FEV1% 
in T2DM diabetic subjects with different grades of reti-
nopathy. There was a decline in PFTs with increasing 
grades of retinopathy but none were statistically signifi-
cant. Table 4 shows correlation of FVC, FEV1 and FE-
V1% with (nephropathy) micro albuminuria and GFR. 
There was no correlation of PFT parameters with 
nephropathy. Table 5 Indicating anthropometric meas-
urements in type 2 diabetics according to duration of 
illness. T2DM subjects were divided into 2 groups 
based on duration of diabetes: 1) those less than 10 
years of diabetes and 2) those more than 10 years of 
diabetes. Both groups did not show any significant 
difference in anthropometric measurements as indicat-
ed in Table 5. Table 6 indicates that there was signifi-
cant positive association of micro albuminuria and neg-
ative correlation of GFR with duration of illness respec-
tively but none of the PFT parameters showed signifi-
cant correlation with increase in duration of diabetes. 
Similarly, as indicated in Table 7, association between 
retinopathy grades and duration of diabetes was ana-
lysed by Chi square for trend (extended to Mantel-
Haenszel) and showed that as, number of diabetic cas-
es with duration more than 10 years increases, reti-
nopathy grades also went on increasing. This directly 
indicates that more the duration of diabetes, severe 
will be the grade of retinopathy. Table 8 indicates a 
significant correlation of micro albuminuria and GFR 
each with diabetic retinopathy. 
DISCUSSION 
There was a significant reduction in FVC, FEV1 and FE-
V1% in type 2 diabetes mellitus as compared to the 
Table 8. Correlation of retinopathy with GFR and micro albuminuria 
  
  
  
Spearman's rho 
  
Parameters Correlations Retinopathy GFR 
Retinopathy Correlation Coefficient 
Sig. (2-tailed) 
1.000 0.662** 
      0.000 
GFR Correlation Coefficient 
Sig. (2-tailed) 
0.662** 1.000 
      0.000 
  Parameters 
Correlations 
Retinopathy Micro albuminuria 
Spearman's rho Retinopathy Correlation Coefficient 
 Sig. (2-tailed) 
1.000 
  
0.569** 
Micro albuminuria Correlation Coefficient 
Sig. (2-tailed) 
0.569** 1.000 
  
      0.000 
**Correlation is significant at the 0.01 level (2-tailed). 
P value= 0.000 significant correlation between retinopathy and GFR 
This shows that higher grades of retinopathy are associated with higher values of GFR 
Correlation between retinopathy and micro albuminuria = 0.569 
P value= 0.000 significant correlation between retinopathy and micro albuminuria  
RETINOPATHY 
Figure 1. FVC and FEV1 values in grade 1,2,3,4 reti-
nopathy 
Figure 2.  Comparative decline in FVC and FEV1 with 
increase in grades of retinopathy  
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control group in the present study. When each of these 
PFT parameters, FVC, FEV1 and FEV1% were correlated 
with micro albuminuria and GFR in T2DM with 
nephropathy there was a positive correlation but it was 
not significant. The PFT parameters were further corre-
lated with different grades of retinopathy, a similar 
decline was seen with increasing grades of retinopathy, 
but the decline was not significant as depicted in Figure 
1 and 2. However, significant correlation was observed 
for microvascular complications, nephropathy and reti-
nopathy in the study. Thus, in the present study, signifi-
cant correlation was observed for microvascular com-
plications nephropathy and retinopathy, but a similar 
correlation was not observed for any PFT parameters 
with either diabetic nephropathy and retinopathy. This 
is thereby suggestive of the fact that presence of reti-
nopathy can be said to act as a red flag for the begin-
ning of or co-existing nephropathy in T2DM. This sig-
nificant association of nephropathy with increasing 
grades of retinopathy may serve to adopt preventive 
measures in diabetic patients with retinopathy from 
proceeding to overt nephropathy and worsening of 
retinopathy. The Diabetes Control and Complications 
Trial (DCCT) have confirmed a strong relationship be-
tween diabetic retinopathy and elevated albumin ex-
cretion.[18] Similar strong association between dia-
betic nephropathy and retinopathy was demonstrated 
by Arora et al.[19]  F He et al 20 in his meta- analysis 
analysed the predictive value of diabetic retinopathy in 
differentiating diabetic nephropathy from non-diabetic 
renal diseases and suggested proliferative diabetic reti-
nopathy to be a highly specific indicator for diabetic 
nephropathy. Shafiee et al [21] in his study on type 2 
diabetic patients with nephropathy found that with 
progression of diabetic nephropathy to more advanced 
stages, there was significant impairment of pulmonary 
function. Also, in study conducted by Cilek P, the de-
gree of proteinuria and frequency of retinopathy corre-
lated with the severity of restrictive lung function in 
diabetic patients.[22] 
I M Stratton [23] in his study on patients with T2DM 
had reported a strong association of complications with 
hyperglycaemia. Sinha et al studied pulmonary func-
tions with macroangiopathic complications in T2DM 
Asian Indian patients and observed no differences for 
pulmonary functions, forced vital capacity, forced ex-
pired volume in one second, peak expiratory flow rate, 
maximal static inspiratory and expiratory pressures but 
significant impairment of pulmonary diffusion capacity 
for carbon monoxide.[24]  
Various studies reported [25, 26, 27, 28] significant 
reduction in diffusion capacity with micro vascular com-
plications like retinopathy, nephropathy and neuropa-
thy and significant positive correlation with high sugar 
levels, long duration of diabetes. The possible patho-
physiological mechanism of illness in diabetes mellitus 
suggested by most authors was thickening of alveolar 
epithelial and pulmonary capillary basal lamina in these 
group of patients. Overall, most studies have investigat-
ed PFTs in diabetic subjects and compared them with 
the same in those diabetics with microvascular compli-
cations. Also, there has been meticulous research on 
association of PFTs with duration of diabetes and gly-
caemic index. But no studies conducted so far have 
studied association of each PFT parameters with both 
microvascular complications retinopathy and nephrop-
athy. Also, comparative association of each microvascu-
lar complication with duration of diabetic illness, has 
not been studied before. The frequency and severity of 
involvement of these complications has hardly been 
compared and evaluated before.  
To study the association of microvascular complications 
with duration of diabetes, We have included this as a 
part of our study to assess the relationship of duration 
of diabetes with intensity of following microvascular 
complications PFTs (lung), nephropathy, retinopathy. 
T2DM subjects in the study were divided into 2 groups, 
those more than 10 years of duration and less than 10 
years. There was significant increase in micro albumi-
nuria and decrease in GFR and also a similar increase in 
grade/ severity of retinopathy respectively with in-
crease in duration of diabetes. However, when PFT 
parameters were analysed, decrease in values of PFT 
parameters FVC, FEV1 and FEV1% with increase in dura-
tion of diabetes was not significant. Thus, unlike PFT 
parameters, micro albuminuria, GFR and retinopathy 
showed a significant association found to be with dura-
tion of diabetes in our study as depicted in Figure 2. 
The significant association of micro albuminuria and 
decreased GFR (nephropathy) with increasing grades of 
retinopathy and also the association of the two with 
increasing duration of diabetes points out to its severi-
ty of involvement unlike PFT which showed a non- sig-
nificant decline with increased duration of diabetes 
illness. This  may also allude to the fact that intensive 
treatment of hyperglycaemia in diabetic subjects with 
retinopathy at earlier stages might hinder its further 
progression to advanced stages of retinopathy and 
serve as a check to early detection and prevention of 
nephropathy in T2DM as well. 
Also T2DM comprises individuals bearing insulin re-
sistance (IR) which is usually relative rather than abso-
lute insulin deficiency. Chronic hyperglycaemia is asso-
ciated with long-term damage and failure of various 
organ systems mainly affecting eyes, nerves, kidneys, 
and heart.[4] The onset T2DM is often silent and insidi-
ous and chronic hyperglycaemia is usually found to be  
existing in most type 2 DM patients even before the 
diagnosis. Also at the onset most of the T2DM are usu-
ally treated with lifestyle modification, dietary advice 
and then followed by oral anti hyperglycemic drugs. 
This stepwise approach may result in further, accumu-
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lation of glycaemic burden. [3] Nephropathy, retinopa-
thy and neuropathy are the most common microvascu-
lar complications in diabetes.[4] Longer the duration of 
diabetes, longer would be the persistence of hypergly-
caemia. The long standing hyperglycaemic state in dia-
betes mellitus results in glucose, forming covalent ad-
ducts with plasma proteins through non-enzymatic 
process known as glycation. [29] This protein glycation 
and formation of advanced glycation end products 
(AGEs) is a major cause in development and progres-
sion of different diabetic complications and has an im-
portant role in the pathogenesis including nephropa-
thy, retinopathy, neuropathy and cardiomyopathy 
along with some other diseases such as rheumatoid 
arthritis, osteoporosis and aging. [30, 31]  Lung has 
abundant connective tissue and dense capillary net-
work which makes it very likely to get affected by dia-
betes mellitus. [5, 6] The glycation of proteins (AGEs) 
alters the normal functions by disrupting molecular 
conformation, altering enzymatic activity, and interfer-
ing with receptor functioning.[30] Collagen is a major 
component of ECM and a prominent target of non-
enzymatic glycation [32]. It is likely that persistent inad-
equate blood glucose control over a period of time 
which is more likely with longer duration of diabetes, 
may alter the regulation of inflammatory pathways that 
are involved in pulmonary function impairment; mainly 
restrictive impairment and reduction in diffusing capac-
ity to carbon monoxide [33].  The complications in lung, 
kidneys, and eyes needs to be compared in severity as 
all three have identical aetiopathogenesis. The devel-
opment of complications in the three, maybe the non-
enzymatic glycosylation of proteins due to chronic hy-
perglycemia which brings about changes in connective 
tissue (collagen and elastin), as well as microangiopa-
thy [34, 35]. The involvement of lungs as compared to 
kidney and retina doesn’t seem to be alarming in our 
study. 
The pulmonary abnormalities may remain subclinical in 
diabetic patients mainly because of the great microvas-
cular reserve in alveolar-capillary system.[36] In spite of 
the presence of a large capillary network in the lung 
and its acknowledgement as one of the organs involved 
in diabetes, pulmonary function tests in diabetes are 
frequently disregarded and not conducted as a regular 
follow up. But this loss of microvascular reserve in the 
lung may become clinically important in case of acute 
or chronic pathological lung conditions like pneumonia, 
chronic obstructive pulmonary disease, asthma and 
heart failure and hence should not be disregarded. [37]  
CONCLUSIONS 
The intensity of lung involvement in type 2 diabetic 
subjects as compared to microvascular complications 
nephropathy and retinopathy was not significant. This 
may be due to the large micro-vascular reserve in alve-
olar capillary system. All type 2 diabetics with retinopa-
thy should be thoroughly investigated for nephropathy 
as both the microvascular complications in type 2 dia-
betes mellitus seem to go hand in hand. The treatment 
modality in those with onset of retinopathy if intensi-
fied could deter further worsening of retinopathy in 
diabetic patients and serve to check the  onset and 
progress of nephropathy and thus may help to reduce 
the morbidity in type 2 diabetic patients. 
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